When asked to comment on both research reports, a Pfizer spokesman said: "We continue to believe... a third dose booster may be needed within six to 12 months after full vaccination to maintain the highest levels of protection."
People who received their second dose of the Pfizer-BioNTech vaccine five or more months ago are more likely to test positive for Covid-19 than people who were fully vaccinated less than five months ago, new data suggests.
Researchers studied nearly 34,000 fully vaccinated adults in Israel who were tested to see if they had a breakthrough case of Covid-19.
Overall, 1.8 per cent tested positive. At all ages, the odds of testing positive were higher when the last vaccine dose was received at least 146 days earlier, the research team reported on Thursday on medRxiv ahead of peer review.
Among patients older than 60, the odds of a positive test were almost three times higher when at least 146 days had passed since the second dose.
Most of the new infections were observed recently, said co-author Eugene Merzon of Leumit Health Services in Israel.
"Very few patients had required hospitalisation, and it is too early to assess the severity of these new infections in terms of hospital admission, need for mechanical ventilation or mortality," he added. "We are planning to continue our research."